Investor Alert - Medical Marijuana Inc. MJNA Cannot Sell

New Post Public Reply Private Reply Replies (0) Message Board
cb11
Investor Alert - Medical Marijuana Inc. MJNA Cannot Sell !!



Cannabis · Hemp · Hanf · Cannabinoids · THC · CBD · Medical · Medicinal ·

FDA · NHI · EMA · JMA · Patient · Patent · License · Audit · Report · SEC ·



MMJ = Medical Marijuana or CBD Hemp !



Medical Marijuana Inc. - Cannot Sell MMJ or CBD Products !!



Seems majority of its Investors mentally very

dependent, that normal commonsense market

considerations are not possible. Just Pumpers

fake oriented !

For example most of them like to believe, that

Registered MMJ or CBD Patients for Pain-Therapy

will pay annually about $ 8000.- to MJNA, when

they at any Pharmacy as even FDA Approved can

get for $ ZERO the principally much more expensive

CBD Sativex which is also killing Pain & Cancer as

it already worldwide does, but FDA Approved the

US Health Insurances completely paying for it !!



100% sure, 99% of Registered Patients are not

willing to pay annually $ 8000.- to MJNA as they

don’t need or not even have the money or with

that money better go for Holiday or do with it

something else in life important, instead of

paying for Companies such as MJNA !



Famous CBD Sativex is now at every Pharmacy available !!!



MJNA at present has the most exposure and

because of this it gets most affected, but for

fairness its necessary to mention that any MJ

Company with desire to sell MMJ Products get

affected by its None FDA Approved Products

the US Health Insurances Therefore Not Pay !!

MJNA is additionally under SEC Investigations.



Small US MJ Companies not able to change

the Handling of the US Health Insurances !!



This for All Investors to think very well about !



PS : GW Pharmaceuticals the producer of its

patented Sativex, by its owner consortium is

related to Big Global Player Companies with

worldwide annual Revenue of about $ 168 Bn.

This only for knowing with what the small US

MJ Companies really dealing with and to see

the present situation as the beginning only !

For the additional Wellness- Products, there

will be coming Companies as Nestle, Unilever,

RedBull, Etc. also to keep well in mind !!

Its not that simple or easy as Pumpers Think !

Additionally New Fed. US MJ Laws to expect,

will KILL MJ THC Content Wellness Products !



MJNA’s “Cibaderm” is a Big Global Player NOVARTIS Brand ; Happy Lawsuits !!

According evidences MJNA Insisting on the Very Old Well Known Brand !



Additionally as known the SEC knocking at MJNA Doors !!

They Call That Inquiry When Doing Investigations ¨!!!



This With Compliments By On2_addict Presented.





As Investor if you may get or got harmed by any Short- Talk Blackmailing

or Misleading MB Members, just add www. to the Posts- Link to send and

File your Claims at ic3.gov CIA & FBI Branch - Internet Crimes, they help !



By The Company Abused, Mislead, Etc. ; Contact SEC Washington

To File Your Claims To Get Compensated !!

SEC Washington Hotline 202 551-6551 - Investors Protection

SEC Office Whistleblower at
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Parents Champion Meta's Online Safety Agreement

Updated Category News Views 5

Any old-timer in the market game will tell you this: safeguarding the next generation runs deeper than just chasing profits. A recent poll by the Coalition to Empower our Future reveals something that ain’t too surprising if you’ve been paying attention. Parents all over the nation are nodding along to Meta’s new move to bolster online protections for younger folks....

Continue Reading
Freeport-McMoRan Hit with Legal Probe: What's Next?

Updated Category News Views 4

Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...

Continue Reading
AEON's AI-Powered Agentic Checkout: A Game Changer?

Updated Category News Views 5

Cracking the Future: AEON Introduces Agentic Checkout There's a new sheriff in the AI economy: AEON, throwing its hat in the ring with the debut of Agentic Checkout. Now if you think we're just talking about basic automation here, think again. This thing's got its own AI Card that transforms your shopping commands into planned purchases. Think of it as handing over your...

Continue Reading
Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 0

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
Pathlock Faces Identity Governance Opportunities in 2026

Updated Category News Views 3

Challenges in Identity Governance Emerge for 2026 Imagine a world where digital identities run wild—unmonitored, orphaned, dormant. Welcome to 2026, where identity governance and administration (IGA) face a reckoning, dragging enterprises into the spotlight as they scramble to protect against identity chaos. With Pathlock’s recent recognition in the Gartner Market...

Continue Reading
Agroz: Awards Fuel Momentum in AgriTech Sphere

Updated Category News Views 3

Agroz Surging Ahead with Global Acclaim There's a new breeze blowing through the AgTech industry, and it's carrying Agroz Inc. (NASDAQ: AGRZ) straight to the top. Fresh off the back of snagging several prestigious international awards, this vertically integrated agricultural tech powerhouse is making waves not just in Malaysia, but on the global stage. Top of the FoodTech...

Continue Reading
Kansas City's Haunts Condense Season to 13 Nights

Updated Category News Views 2

A Scary Short Season Takes Center Stage Hold onto your ghost hats, folks! The Kansas City haunt legends are shaking things up with a shorter scare season. This October, the infamous Edge of Hell and The Beast attractions are packing in the frights over just 13 nights, shifting their schedule due to rising September temperatures. Now, ain't that something? For their 52nd...

Continue Reading
AEVEX Faces $100K+ Losses in New Investor Lawsuit

Updated Category News Views 1

When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...

Continue Reading

Top 5 Most Recently Viewed Articles

Phathom Pharmaceuticals Announces Upcoming Investor Engagements

Updated Category News Views 23

Phathom Pharmaceuticals Upcoming Investor Conferences Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a dedicated biopharmaceutical company, is making strides in the realm of gastrointestinal (GI) diseases. The company aims to develop groundbreaking treatments that can substantially improve the lives of patients suffering from such conditions. Today, we share exciting news...

Continue Reading
Create Advertising Shifts Leadership as Industry Evolves

Updated Category News Views 3

Leadership Shakeup in Creative Advertising After more than two decades, the baton at Create Advertising Group has moved into new hands. Jonathan Gitlin rises to the top spot as CEO, succeeding founder David Stern. Stern isn't disappearing though—he’s sticking around as Chairman to steer long-term strategy, underscoring a shift but not a complete departure from the old...

Continue Reading
Mugler's Creative Journey Explored in New Documentary Film

Updated Category News Views 120

The Dream Unveiled: Mugler - A Cinematic Experience This upcoming documentary invites viewers on a captivating journey into the world of Mugler, delving into the brand's evolution and artistry. Directed by Matthieu Menu, this compelling film captures the essence of Mugler's distinct vision while honoring its remarkable 50-year legacy. A Close Look at Mugler's Legacy The...

Continue Reading
Labrador Gold Advances Exploration Programs at Key Sites

Updated Category News Views 133

Labrador Gold Exploration Update on Hopedale and Borden Lake Projects In a recent announcement, Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6), commonly referred to as LabGold, shared exciting updates regarding its ongoing exploration programs at the Hopedale and Borden Lake Extension gold projects. These initiatives showcase the company's commitment to...

Continue Reading
Kyndryl's Strategic €100 Million Investment in Digital Innovation

Updated Category News Views 189

Kyndryl's Strategic €100 Million Investment in Digital Innovation Kyndryl, a prominent provider of enterprise technology services, is set to invest up to €100 million over three years to boost the digital transformation landscape in France. This initiative not only targets technological advancement but also aims to create job opportunities, particularly in areas of...

Continue Reading